Tailoring AML Treatment With Currently Available Agents

An engaging roundtable discussion on the current treatment landscape for acute myeloid leukemia (AML) is led by Amer M. Zeidan, MBBS, of Yale School of Medicine. This expert panel shares insights into the latest advancements, clinical challenges, and innovative therapies transforming AML care. The discussion covers topics such as personalized treatment approaches, novel therapies, and strategies to improve patient outcomes.